Reports Q4 revenue $50.74M vs $37.51M last year. “We’re thrilled to announce another exceptional year of financial performance at Viemed, marked by robust double-digit annual growth and sustained profitability,” said Casey Hoyt, Viemed’s CEO. “We are particularly pleased with the Company’s capacity to generate free cash flow, enabling us to fuel continued strong growth. This underscores the effectiveness of our strategic initiatives and the dedication of our entire team. These accomplishments reaffirm our commitment to delivering enduring value to our stakeholders.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on VMD: